Study of cm559 in healthy volunteers
This trial tests a new drug called CM559 in healthy people to see if it is safe. If you are between 18 and 60 years old and generally healthy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must be in good general health.
- You cannot smoke more than 5 cigarettes a day on average in the last 3 months.
- You must not drink heavily or be unable to avoid alcohol during the study.
- You cannot have a history of drug abuse in the past year.
- You cannot have donated blood or lost more than 400 mL of blood in the last 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early Phase 1 trial testing a new investigational drug called CM326 given as an injection. The study measures how your body absorbs, distributes, and eliminates the drug. Researchers are enrolling only healthy volunteers to understand the drug's basic safety and how it moves through the body.
This trial tests a new drug called CM383 in healthy people to see how it affects the body. It may help researchers learn if CM383 is safe and how it works.
This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.